异动解读|ASMPT盘中上涨15.25%,多家大行密集上调目标价催化强势反弹

行情直击
Jul 31

7月31日,ASMPT盘中上涨15.25%,报153.1港元,成交额2.11亿港元。

消息面上,公司7月28日发布中期业绩后,多家国际大行于7月30日密集发布正面评级:美银维持"买入"目标价310港元,花旗重申"买入"目标价250港元,里昂维持"跑赢大市"目标价226.2港元,摩根大通维持"增持"目标价225港元,华泰上调目标价至205港元。各行目标价较当前股价存在显著上行空间。

业绩方面,ASMPT第二季收入49.36亿港元,同比增长45%;经调整纯利6.38亿港元,较市场预期高出76%;订单70.8亿港元,订单出货比达1.43倍。公司CEO此前亦表态AI驱动的设备长期需求稳固,第三季收入指引中位数较市场共识高出11%。此前股价自高位回调逾三成后,密集利好推动资金快速回补。

ASMPT是半导体和电子产品制造领域硬件及软件解决方案的全球供应商,核心业务涵盖先进封装及SMT解决方案。

(以上内容均基于市场公开消息,由程序或算法智能生成,仅作为股价异动提醒,不作为投资建议或交易依据。)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10